Olema Pharmaceuticals OLMA Institutional Ownership

Updated Oct 10, 2026

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) had 186 institutional holders reporting a position on Form 13F for the quarter ended June 30, 2026.

• These investors held 97.58% of Olema Pharmaceuticals' outstanding shares at the end of Q2 2026, down from 98.71% in Q1 2026.
• Total shares held in OLMA rose 0.45% from Q1 2026; the number of holders rose 56.30% from Q2 2025.
• Looking at the 186 holders of OLMA individually, 100 added to their positions, 61 reduced their stakes and 25 left their positions unchanged.
• In total, institutional investors held 101.92Mn shares of Olema Pharmaceuticals at the end of Q2 2026, up 454K from the prior quarter and up 34.55Mn from a year earlier.
• FMR LLC led 13F holders of OLMA with 12.14Mn shares as of June 30, 2026, or 11.63% of shares outstanding.
• The biggest increases in OLMA positions during Q2 2026 came from FMR LLC (+1.76Mn shares), Franklin Templeton Inc (+1.13Mn shares), Vanguard Portfolio Management LLC (+1.07Mn shares), BlackRock, Inc. (+1.06Mn shares) and Point72 Asset Management, L.P. (+999.84K shares).
• The largest position reductions in OLMA for Q2 2026 were by Cormorant Asset Management, LP (-1.75Mn shares), Woodline Partners LP (-731K shares), Defilade Capital Management, L.P. (-579.78K shares), Bain Capital Life Sciences Investors, LLC (-387.99K shares) and T. Rowe Price Associates Inc (-356.27K shares).
• According to Business Quant data, the leading holders of OLMA for Q2 2026 were FMR LLC (12.14Mn shares), Paradigm Biocapital Advisors LP (8.67Mn shares), Jupiter Topco LLC (7.09Mn shares), Bain Capital Life Sciences Investors, LLC (7.09Mn shares), BlackRock, Inc. (6.71Mn shares), BVF Inc (5.3Mn shares), Siren, L.L.C. (4.86Mn shares), State Street Corp (4.32Mn shares), Vanguard Capital Management LLC (3.34Mn shares) and Logos Global Management LP (3.21Mn shares).